-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Outlook Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2016 to 2023.
- Outlook Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 25.5M shares, a 98.4% increase year-over-year.
- Outlook Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 250M shares, a 18% increase from 2022.
- Outlook Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 212M shares, a 38.9% increase from 2021.
- Outlook Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 153M shares, a 110% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)